Label: LIGHTENING DAY CREAM- polyethylene glycol 400 cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

Drug Label Information

Updated 07/12

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    KEY ACTIVE INGREDIENTS
    Seaweed, Licorice Root and White Tea Extract Close
  • PURPOSE

    This Whitening Seaweed inhibits melanin synthesis and reduces pigmentation of synthesized melanins with elimination of pigmented scales.
    Close
  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children.
    Close
  • INDICATIONS & USAGE

    LIGHTENING DAY CREAM LANGE
    A light and moisturizing cream, to help:
    Inhibit skin pigmentation,
    Nourish and moisturize the skin.
    Close
  • WARNINGS

    WARNING!
    Avoid contact with the eyes;
    Avoid or afford protecting from UV
    whilst using products containing AHA
    because of the suggestion of susceptibility to
    increased damage from UV.

    Close
  • DOSAGE & ADMINISTRATION

    50 mL
    1.7 FL. OZ
    Close
  • INACTIVE INGREDIENT

    WATER (AQUA)
    GLYCERIN
    PEG-8
    DICAPRYLYL CARBONATE
    GLYCERYL STEARATE SE
    ISONONYL ISONONANOATE
    CAMELLIA KISSI SEED OIL
    DIMETHICONE
    POLYACRYLAMIDE
    PHENOXYETHANOL
    PROPYLENE GLYCOL
    CETYL ALCOHOL
    STEARIC ACID
    XANTHAN GUM
    C13-14 ISOPARAFFIN
    SODIUM PCA
    DISODIUM EDTA
    PROPYLPARABEN
    METHYLPARABEN
    LAURETH-7
    MAGNESIUM ASCORBYL PHOSPHATE
    MENTHOXYPROPANEDIOL
    o-CYMEN-5-OL
    GLYCERYL POLYACRYLATE
    GLYCERYL ACRYLATE/ACRYLIC ACID COPOLYMER
    ETHYLPARABEN
    GLYCYRRHIZA GLABRA (LICORICE) ROOT EXTRACT
    BUTYLENE GLYCOL Close
  • PRINCIPAL DISPLAY PANEL

    image of carton label
    LANGE
    PARIS
    LIGHTENING DAY CREAM
    Morning radiance with Seaweed extracts
    50 ml
    1.7 FL. OZ Close
  • INGREDIENTS AND APPEARANCE
    LIGHTENING DAY CREAM 
    dicaprylyl carbonate cream
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:51830-019
    Route of Administration TOPICAL DEA Schedule     
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) (POLYETHYLENE GLYCOL 400 - UNII:B697894SGQ) POLYETHYLENE GLYCOL 400 2.5 mg  in 50 mg
    Inactive Ingredients
    Ingredient Name Strength
    DICAPRYLYL CARBONATE (UNII: 609A3V1SUA)  
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    GLYCERYL STEARATE SE (UNII: FCZ5MH785I)  
    CAMELLIA KISSII SEED OIL (UNII: 96HGN0T99A)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    C13-14 ISOPARAFFIN (UNII: E4F12ROE70)  
    SODIUM PYRROLIDONE CARBOXYLATE (UNII: 469OTG57A2)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    LAURETH-7 (UNII: Z95S6G8201)  
    3-((L-MENTHYL)OXY)PROPANE-1,2-DIOL (UNII: KD6TZ2QICH)  
    O-CYMEN-5-OL (UNII: H41B6Q1I9L)  
    ETHYLPARABEN (UNII: 14255EXE39)  
    GLYCYRRHIZA GLABRA (UNII: 2788Z9758H)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    POLYACRYLAMIDE (10000 MW) (UNII: E2KR9C9V2I)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    ACRYLIC ACID (UNII: J94PBK7X8S)  
    MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5)  
    ISONONYL ISONONANOATE (UNII: S4V5BS6GCX)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:51830-019-04 50 mg in 1 CONTAINER
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    unapproved drug other 07/18/2012
    Labeler - LANGE SAS (275956105)
    Registrant - LANGE SAS (275956105)
    Establishment
    Name Address ID/FEI Business Operations
    LANGE SAS 275956105 manufacture(51830-019)
    Close